0000905718-15-000774.txt : 20150914 0000905718-15-000774.hdr.sgml : 20150914 20150914082139 ACCESSION NUMBER: 0000905718-15-000774 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150911 FILED AS OF DATE: 20150914 DATE AS OF CHANGE: 20150914 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-200-7500 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CATLIN AVERY W CENTRAL INDEX KEY: 0001255348 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 151104707 MAIL ADDRESS: STREET 1: 241 CENTRAL STREET CITY: HINGHAM STATE: MA ZIP: 02043 4 1 avery_form4sept112015.xml OWNERSHIP DOCUMENT X0306 4 2015-09-11 0 0000744218 Celldex Therapeutics, Inc. CLDX 0001255348 CATLIN AVERY W C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD HAMPTON NJ 08827 0 1 0 0 Sr. VP & CFO Common Stock, par value $0.001 per share 2015-09-11 4 M 0 10000 4.5 A 35109 D Incentive Stock Option 4.5 2015-09-11 4 M 0 10000 0 D 2013-01-21 2020-01-21 Common Stock 10000 7847 D Includes 500 shares of common stock acquired under the Company's 2004 Employee Stock Purchase Plan on June 30, 2015. As of January 21, 2014, the option was fully vested. /s/ Anthony S. Marucci, attorney in fact for Avery W. Catlin 2015-09-11